返回
Mirxes Holding Company Limited（02629.HK）價格
02629.HK 股價走勢圖
MIRXES-B (02629.HK)
Mirxes Holding Company Limited
HK$41.5
-7.77%
$-3.5
休市： Jan 16, 16:00:00 HKT
關鍵數據
前收市價
$44.46
開盤價
$45
當日範圍
$41.12 - $45
52週區間
$27.05 - $77.3
交易量
450.7K
平均成交量
748.9K
每股盈餘 (TTM)
-2.15
股息收益率
--
市值
$12.3B
什麼是 MIRXES-B？
Mirxes Holding Co., Ltd. operates as an investment holding company. The company employs 347 full-time employees The company went IPO on 2025-05-23. The company develops and commercializes accurate, non-invasive, and affordable blood-based miRNA test kit products for the early detection of cancer and other diseases. Its segments include Infectious diseases and Early detection and precision multi-omics. Its solutions include cancer screening; clinical sequencing; cancer treatment selection, and infectious diseases. Its core product (namely, GASTROClear), two other commercialized products (namely, LUNGClear and Fortitude), and six product candidates at pre-clinical stage. GASTROClear is a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening. LUNGClear, its lung cancer screening product candidate, is a detection panel consisting of miRNA biomarkers discovered and verified in multi-center studies. The company offers complete COVID-19 testing solutions.
